Welcome to ISLB

Founded in 2017 in the city of Granada, in Spain and with a global reach: by joining those ...

As a member, you can enjoy the benefits of educational opportunities and be eligible...


Our partners and collaborators

Copy of Copy of Copy of Copy of Copy of

Official Journal

Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.

Copy of Copy of Copy of Copy of Copy of

Webinar series

Circulating Tumor Cells and Controversies in LBs: from the clinical practice to the new frontier.

The Lectures are now available

Screenshot 2020-11-24 at 10.43.45 PM.png


Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy


The International Society of Liquid Biopsy (ISLB), is an international professional organization committed to the advancement of the Liquid Biopsy and the promotion of a multidisciplinary approach for the diagnosis and treatment of patients based on then use of liquid biopsies.


Joining ISLB is to join an international community of professionals in this discipline who share best practices and the latest knowledge in the use of Liquid Biopsy for the definitive implementation of this technology in the treatment and care of cancer and other diseases that could benefit from the use of Liquid Biopsy.


Because of advances in DNA sequencing technology, doctors can pick up on these traces of DNA, and use them to track the mutations present in a cancer. Finding out this information helps doctors keep track of a patient's tumour and whether treatment is working, or find out early if a new scan or different treatment is needed.


Credit to: Cancer Research UK and Phospho Biomedical Animation

Liquid biopsies to monitor cancer 

Being able to easily track cancer is vital in all stages of the disease. Doctors have long been able to monitor the disease with scans and by taking small tissue samples (biopsies), but now a new technique is becoming available to them: the liquid biopsy, which can deliver a lot of detailed information about a patient's tumour from a simple blood sample.


So how does it work? Inside a tumour, cells are growing at a high rate, but while many cancer cells are growing, some are also dying in a process called apoptosis. As dying cancer cells break up, they release fragments of their DNA. Some of that DNA can get into the blood stream, after which it's called circulating tumour DNA (or ctDNA). This circulating tumour DNA is ready for scientists to fish out with a simple blood sample.

press to zoom

press to zoom

press to zoom

press to zoom
Screenshot 2020-11-25 at 2.17.06 PM.png
image001 (1).png